Evolve BioPep
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Evolve BioPep between 6 Oct 2025 and 9 Feb 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Evolve BioPep
Retatrutide
Tested 4 Samples
Last test 9 Feb 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Evolve BioPep
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
9 Feb 2026
First
6 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 9 Feb 2026 | View | 10mg | 10.3mg | +3.0% | 98.57% | (no batch ID) | Silver Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 26 Jan 2026 | View | 10mg | 10mg | 99.80% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab G | Public | ||
| 15 Jan 2026 | View | 5mg | 4.8mg | -4.0% | 99.60% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab G | Public | |
| 6 Oct 2025 | View | 10mg | 13.2mg | +32.0% | 98.30% | 07/28/25 | Silver Label / Silver Crimp / Yellow Cap | Lab G | Public | |